NADAL
Dead / Abandoned — Abandoned — after ex parte appeal (as of 01 Jun 2022)
What this means for you
This application is over — abandoned 01 Jun 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79296387
- Mark type
- Stylized text
- Filed
- 28 Jul 2020
- Abandoned
- 01 Jun 2022
- Attorney of record
- CHRISTOPHER J VOCI
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic and analysis agents, preparations and reagents for medical and veterinary purposes, namely, for testing of allergies, autoimmunity diseases, presence of bacteria, diabetes, blood glucose levels, inflammation, fertility or infertility, pregnancy, sexually transmitted diseases, urinary tract infections, cancer, hormonal disorders, immune status, presence of fungi, presence of viral markers, infectious diseases, food intolerances, kidney dysfunction, liver dysfunction, thyroid gland dysfunction, cardiovascular dysfunction, or metabolic dysfunction; test strips for medical and veterinary purposes for testing the presence of allergies, autoimmunity markers, bacteria, fungi, viral markers, diabetes markers, inflammation markers, fertility hormones, pregnancy hormones, fertility markers, markers for sexually transmitted diseases, markers for urinary tract infections, markers for infectious diseases, endocrinology markers, metabolic markers, tumor markers, hormones, blood markers, markers for food intolerances, markers for kidney dysfunction, markers for liver dysfunction, markers for thyroid gland dysfunction, markers for cardiovascular dysfunction or markers for metabolic dysfunction, for testing immune status, urine, or blood glucose levels; immunological quick tests for instant diagnostics; medical diagnostic preparations, in particular diagnostic quick tests, for use in the fields of infectology, pediatrics, gynecology, bacteriology, urology, latex agglutination, cardiology, oncology and drug analysis; reagents for use in diagnostic pregnancy tests; reagents for use in ovulation tests for medical purposes; reagents for use in diagnostic HIV tests; reagents for use in drug tests for medical purposes; myocardial infarction markers; diagnostic agents and preparations in the nature of test stripes, test cassettes, multi-line tests, test liquids, ELISA tests, EIAs (enzyme immuno assays), or dry chemistry assay kits for detecting infectious diseases
Owner
Prosecution history
- 19 Jun 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 01 Jun 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 01 Jun 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 01 Jun 2022 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 01 Jun 2022 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 01 Jun 2022 — ABANDONMENT - AFTER EX PARTE APPEAL
- 01 Jun 2022 — EXPARTE APPEAL TERMINATED
- 19 Apr 2022 — EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
- 17 Apr 2022 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 27 Mar 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 23 Mar 2022 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 01 Feb 2022 — NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
- 01 Feb 2022 — ACTION DENYING REQ FOR RECON E-MAILED
- 01 Feb 2022 — ACTION CONTINUING FINAL - COMPLETED
- 07 Jan 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED